Slice Engineering Mosquito Prime Hotend Targets Speed and Reliability in 3D Printing
Florida-based Slice Engineering has launched the Mosquito Prime hotend, catering to the increasing demand for faster and more reliable 3D printing. The hotend offers improved thermal engineering and lightweight construction for high-flow extrusion and consistent high-quality prints.
Finding Fires With Lightning Speed
To address this urgent problem, Fire Neural Network (FNN), a company based in Gainesville, Florida, is utilizing artificial intelligence (AI) to expedite the identification of devastating wildfires from 24 hours to just 40 seconds.
You’re More Than the Phone in Your Hand: Entrepreneurial Hack of the Week
In a world where technology reigns supreme, concerns about AI's threat to jobs and the erosion of human relationships have reached a tipping point. But what if there's a genius hack to strike the perfect balance? In this thought-provoking article, Karl LaPan, Director of UF Innovate Accelerate, unravels the intricate relationship between technology, AI, and our fundamental need for genuine human connection.
MLM Biologics Developing Wound Infection Prevention Device for Military
MLM Biologics Inc., a graduate company of Sid Martin Biotech, has been awarded nearly $1.5 million by the US Army to develop a device that prevents infection in battlefield wounds. The device will utilize MLM Biologic's collagen processing and stabilization technologies. The focus is on preventing infection in complex, traumatic injuries in austere environments. The company plans to incorporate their proprietary technologies and proven anti-inflammatory and anti-microbial components, with potential civilian use in the future.
Tech Tuesday: Slice Engineering
This week's Tech Tuesday features UF Innovate | Accelerate resident client Slice Engineering, which is developing a new wave of design and production in the growing field of 3D printing.
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
CohBar, Inc. and Morphogenesis, Inc., a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies, have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
Tech Tuesday: Start-Up Company Tips with UF Innovate Accelerate Director, Karl LaPan
In this week's Tech Tuesday, join us as UF Innovate and SCAD Media introduce Karl LaPan, Director of UF Innovate Accelerate, who shares invaluable tips for startup success. Karl emphasizes the significance of cash flow management, the value of trustworthy partners, and other essential strategies to help startups navigate uncertainties and maximize their chances of achieving success.
Concept Companies: Cutting-Edge Growth With Responsible Leadership
Concept Companies, led by Brian Crawford, is a visionary force in the commercial real estate industry. As a prominent concierge real estate development firm, Concept Companies is at the forefront of revolutionizing the regional and national market with its innovative approach to development.
Entrinsic Bioscience Unveils Animal Study on Breakthrough Hydration Technology
A patented blend of amino acids will be part of the next generation of oral rehydration solutions, according to an animal study conducted by a team of researchers at Entrinsic Bioscience. The study demonstrated that the blend of amino acids was more efficient in transporting electrolytes and fluids than the glucose-based oral rehydration solution (ORS) recommended by the World Health Organization. The formula also decreased epithelial anion channel activity and improved intestinal barrier function at a greater level. The two formulas were tested in animals which had diarrhea induced through cholera toxin.
Baptist Health Study Suggests Plant-Based Amino Acid Drink Lessens Chemotherapy Side Effects
Baptist Health Louisville (Kentucky) is looking for ways to help cancer patients fight the side effects of chemotherapy.
Researchers are studying a new plant-based amino acid drink, Enterade, product of UF startup and UF Innovate | Accelerate alumnus company Entrinsic Bioscience, LLC.
